WO2020055356A3 - Inhalation compositions comprising anti-bacterial agents - Google Patents

Inhalation compositions comprising anti-bacterial agents Download PDF

Info

Publication number
WO2020055356A3
WO2020055356A3 PCT/TR2019/050564 TR2019050564W WO2020055356A3 WO 2020055356 A3 WO2020055356 A3 WO 2020055356A3 TR 2019050564 W TR2019050564 W TR 2019050564W WO 2020055356 A3 WO2020055356 A3 WO 2020055356A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacterial agents
inhalation compositions
inhalation
compositions
lubricant
Prior art date
Application number
PCT/TR2019/050564
Other languages
French (fr)
Other versions
WO2020055356A2 (en
Inventor
Ali Turkyilmaz
Irem Yenice
Devrim Celik
Arzu CAYIR
Original Assignee
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Arven Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to EP19860985.1A priority Critical patent/EP3823602A4/en
Publication of WO2020055356A2 publication Critical patent/WO2020055356A2/en
Publication of WO2020055356A3 publication Critical patent/WO2020055356A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Abstract

The invention relates to dry powder pharmaceutical compositions administered by means of inhaler devices comprising at least one anti-bacterial agent wherein the composition is free of lubricant and surfactant.
PCT/TR2019/050564 2018-07-20 2019-07-11 Inhalation compositions comprising anti-bacterial agents WO2020055356A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP19860985.1A EP3823602A4 (en) 2018-07-20 2019-07-11 Inhalation compositions comprising anti-bacterial agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2018/10404 2018-07-20
TR201810404 2018-07-20

Publications (2)

Publication Number Publication Date
WO2020055356A2 WO2020055356A2 (en) 2020-03-19
WO2020055356A3 true WO2020055356A3 (en) 2020-05-14

Family

ID=69776573

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050564 WO2020055356A2 (en) 2018-07-20 2019-07-11 Inhalation compositions comprising anti-bacterial agents

Country Status (2)

Country Link
EP (1) EP3823602A4 (en)
WO (1) WO2020055356A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053149A1 (en) * 2007-08-24 2009-02-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Surfactant-based antimicrobial solution for inhalation
WO2012166070A1 (en) * 2011-06-02 2012-12-06 Mahmut Bilgic Dry powder formulation with improved flow characteristics
WO2013109210A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising budesonide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101155806A (en) * 2005-04-06 2008-04-02 法玛西雅厄普约翰有限责任公司 Oxindole oxazolidinone as antibacterial agent
EP2448571B1 (en) * 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
US20120065170A1 (en) * 2010-09-10 2012-03-15 Micurx Pharmaceuticals, Inc. Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053149A1 (en) * 2007-08-24 2009-02-26 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Surfactant-based antimicrobial solution for inhalation
WO2012166070A1 (en) * 2011-06-02 2012-12-06 Mahmut Bilgic Dry powder formulation with improved flow characteristics
WO2013109210A1 (en) * 2012-01-16 2013-07-25 Mahmut Bilgic Dry powder formulations comprising budesonide

Also Published As

Publication number Publication date
EP3823602A2 (en) 2021-05-26
EP3823602A4 (en) 2022-04-27
WO2020055356A2 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
EP4311541A3 (en) Cryoprotective agents for particulate formulations
WO2015120110A3 (en) Novel pharmaceutical formulations
DOP2019000117A (en) NEW DERIVATIVES OF QUINOLINA
DOP2020000023A (en) NEW QUINOLINE DERIVATIVES
WO2015160842A8 (en) Methods and formulations of capsaicinoids and capsinoids
NZ723838A (en) Cannabinoid compositions and uses
MX354828B (en) Monovalent metal cation dry powders for inhalation.
WO2020198403A3 (en) Compositions comprising modified circular polyribonucleotides and uses thereof
DOP2019000275A (en) NEW BICYCLIC PIRAZOLE DERIVATIVES
CO2020013876A2 (en) New quinoline derivatives
WO2016100578A3 (en) Antimicrobial polymyxins for treatment of bacterial infections
MY175781A (en) Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation
NZ731059A (en) An inhalable rapamycin formulation for the treatment of pulmonary hypertension
MX2021001272A (en) Bismuth-thiol compositions and methods of use.
MX2021000700A (en) Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis.
PH12020551341A1 (en) 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
BR112018014839A2 (en) glucomannan containing prolonged release pharmaceutical compositions and properties to prevent misuse
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
WO2020055357A3 (en) Inhalation compositions comprising phosphodiesterase-4 inhibitor
WO2020055356A3 (en) Inhalation compositions comprising anti-bacterial agents
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
EP3400214A4 (en) Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
EP3949963A4 (en) Novel compound and composition for prevention or treatment of respiratory diseases comprising same as active ingredient
WO2020013793A3 (en) Inhalation compositions comprising dopamine agonists
MX2022002185A (en) Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and use thereof.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19860985

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019860985

Country of ref document: EP

Effective date: 20210222

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19860985

Country of ref document: EP

Kind code of ref document: A2